Latest Imris Inc (IMRS) Headlines
IMRIS (IMRS) Research Report Issued By WealthMakers.com
M2 - Wed Mar 12, 11:23AM CDT
March 12, 2014 / M2 PRESSWIRE / WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued a new research report today on IMRIS (NASDAQ: IMRS). The report highlights the short term bullish pattern that has emerged, the SqueezeTrigger Price of $3.75 and the projected fundamental valuation of $4.14.
IMRIS (IMRS) Enters Oversold Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 8:54AM CDT
IMRIS (IMRS) Enters Oversold Territory
IMRIS reports 2013 fourth quarter and full-year financial results
PR Newswire - Tue Mar 04, 3:00PM CST
-- Company completes transition year and lays foundation for profitable growth;
IMRIS CEO Jay D. Miller to present at Cowen 34th Annual Health Care Conference
PR Newswire - Fri Feb 28, 9:30AM CST
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) will present at the Cowen 34th Annual Health Care Conference in Boston at 8:45 am Eastern Time on Wednesday, March 5.
IMRIS to hold fourth quarter and annual 2013 financial results conference call
PR Newswire - Fri Feb 28, 9:20AM CST
IMRIS Inc. (NASDAQ: IMRS; TSX: IM)
IMRIS receives Australian regulatory clearance for intraoperative CT solution
CNW Group - Wed Feb 26, 7:00AM CST
VISIUS iCT listing expands availability of state-of-the-art imaging with low dose management accessed effortlessly in the OR
IMRIS launches world's first MR-safe and CT-compatible neurosurgical horseshoe headrest
PR Newswire - Wed Feb 19, 9:45AM CST
Provides non-rigid head positioning for pediatric and adult patients during brain surgery and intraoperative imaging in the VISIUS Surgical Theatre
IMRIS awarded US FDA clearance for new VISIUS Surgical Theatre with Siemens MR scanners, providing highest intraoperative image quality and best workflow
M2 - Fri Feb 14, 5:48AM CST
Image guided therapy company IMRIS Inc (NASDAQ:IMRS (TSX:IM) reported on Thursday the receipt of approval from the US Food and Drug Administration for the newest generation VISIUS Surgical Theatre that integrates Siemens' latest high-field MR scanners.
IMRIS receives FDA clearance for next generation VISIUS Surgical Theatre
CNW Group - Thu Feb 13, 2:11PM CST
Most advanced Siemens MR scanners provide highest intraoperative image quality and best workflow available
Georgia's Electric Membership Corporations Outage Update
PR Newswire - Thu Feb 13, 9:25AM CST
As of 10:00 a.m. today, Georgia's electric membership cooperatives (EMCs) are reporting approximately 145,000 customers without power as a result of snow and sleet blanketing much of north and central Georgia. Since the storm began, power has been restored to more than 83,000 customers.
IMRIS, Inc. (IMRS) in Focus: Stock Rises 11.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 13, 7:44AM CST
IMRIS, Inc. was a big mover last session, as the company saw its shares surge 11% on the day.
3 Stocks Under $10 to Trade for Breakouts
at The Street - Wed Feb 12, 5:00AM CST
These under-$10 stocks are within range of triggering breakout trades.
4 Stocks Under $10 Moving Higher
at The Street - Fri Feb 07, 8:31AM CST
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
IMRIS, Inc. (IMRS) in Focus: Stock Rises 5.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 28, 7:44AM CST
IMRIS, Inc. was a big mover last session, as the company saw its shares gain nearly 6% on the day.
IMRIS (IMRS) Research Report Issued By WealthMakers.com
M2 - Wed Mar 12, 11:23AM CDT
March 12, 2014 / M2 PRESSWIRE / WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has issued a new research report today on IMRIS (NASDAQ: IMRS). The report highlights the short term bullish pattern that has emerged, the SqueezeTrigger Price of $3.75 and the projected fundamental valuation of $4.14.
IMRIS (IMRS) Enters Oversold Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 11, 8:54AM CDT
IMRIS (IMRS) Enters Oversold Territory
IMRIS reports 2013 fourth quarter and full-year financial results
PR Newswire - Tue Mar 04, 3:00PM CST
-- Company completes transition year and lays foundation for profitable growth;
IMRIS CEO Jay D. Miller to present at Cowen 34th Annual Health Care Conference
PR Newswire - Fri Feb 28, 9:30AM CST
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) will present at the Cowen 34th Annual Health Care Conference in Boston at 8:45 am Eastern Time on Wednesday, March 5.
IMRIS to hold fourth quarter and annual 2013 financial results conference call
PR Newswire - Fri Feb 28, 9:20AM CST
IMRIS Inc. (NASDAQ: IMRS; TSX: IM)
IMRIS receives Australian regulatory clearance for intraoperative CT solution
CNW Group - Wed Feb 26, 7:00AM CST
VISIUS iCT listing expands availability of state-of-the-art imaging with low dose management accessed effortlessly in the OR
IMRIS launches world's first MR-safe and CT-compatible neurosurgical horseshoe headrest
PR Newswire - Wed Feb 19, 9:45AM CST
Provides non-rigid head positioning for pediatric and adult patients during brain surgery and intraoperative imaging in the VISIUS Surgical Theatre
IMRIS awarded US FDA clearance for new VISIUS Surgical Theatre with Siemens MR scanners, providing highest intraoperative image quality and best workflow
M2 - Fri Feb 14, 5:48AM CST
Image guided therapy company IMRIS Inc (NASDAQ:IMRS (TSX:IM) reported on Thursday the receipt of approval from the US Food and Drug Administration for the newest generation VISIUS Surgical Theatre that integrates Siemens' latest high-field MR scanners.
IMRIS receives FDA clearance for next generation VISIUS Surgical Theatre
CNW Group - Thu Feb 13, 2:11PM CST
Most advanced Siemens MR scanners provide highest intraoperative image quality and best workflow available
Georgia's Electric Membership Corporations Outage Update
PR Newswire - Thu Feb 13, 9:25AM CST
As of 10:00 a.m. today, Georgia's electric membership cooperatives (EMCs) are reporting approximately 145,000 customers without power as a result of snow and sleet blanketing much of north and central Georgia. Since the storm began, power has been restored to more than 83,000 customers.
IMRIS, Inc. (IMRS) in Focus: Stock Rises 11.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 13, 7:44AM CST
IMRIS, Inc. was a big mover last session, as the company saw its shares surge 11% on the day.
3 Stocks Under $10 to Trade for Breakouts
at The Street - Wed Feb 12, 5:00AM CST
These under-$10 stocks are within range of triggering breakout trades.
4 Stocks Under $10 Moving Higher
at The Street - Fri Feb 07, 8:31AM CST
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
IMRIS, Inc. (IMRS) in Focus: Stock Rises 5.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 28, 7:44AM CST
IMRIS, Inc. was a big mover last session, as the company saw its shares gain nearly 6% on the day.
